Documents

Assessment of a new plant extract-based product in rhinosinusitis

ZASRITSKAIA I.
Professor,
Kolomiychenko Institute of Otorhinolaryngology,
Ukrainian Academy of Medical Science

ZABOLOTNY D.
Member of he Ukrainian Academy of Medical Science,
Kolomiychenko Institute of Otorhinolaryngology,
Ukrainian Academy of Medical Science

Therapeutics and Clinical Risk Management.
Special Issue in Spanish. Supplement I 2006.
Therapeutics and clinical risk management 2006 - PDF


ABSTRACT

In spite of the treatments currently available for sinusitis, a not insignificant percentage of patients suffer from complications caused by the rhinosinusitis, with relapses and chronification of the process in some cases.

It is therefore necessary to find other alternatives that are able to improve treatment efficacy, diminishing the symptoms and the possible complications, without being associated with side effects. In recent years, a product obtained from plant extracts has been developed that facilitates natural secretion in the nasal cavity and paranasal sinuses, thereby clearing the accumulated mucus.
The goal of this study was to analyse the plant extracts' effect on rhinosinusitis in a sample of 11 children and 24 adults.

The results of our study show that the plant extracts are useful in acute rhinosinusitis.


Assessment of a new plant extract-based product in rhinosinusitis - Full article

Therapeutics and clinical risk management 2006 - Index

Use of a plant-based product in children with acute rhinosinusitis - Next abstract

Hartington Pharma owns Nasodren® for sinusitis treatment